Research Lines of Schizophrenia

Reading time: 1 min

The future necessarily depends on neurobiological research and increased knowledge about the disease. Further study into the genetic bases, including both disease markers and causes, as well as the use of neuroimaging techniques in association with neuropsychological tests, will support the diagnosis with empirical and objective data.

Molecular biology will doubtlessly open the way to a greater understanding of the biological bases underlying schizophrenia and foster the long-term development of genuine antischizophrenic drugs, with new mechanisms of action, administration routes and therapeutic targets. This strategy will place a special emphasis on the negative symptoms and precognitive drugs.

Clinical research

Discover the projects and active clinical trials on this disease.
Go to list

Substantiated information by:

Eduard Parellada Rodon
Miguel Bernardo Arroyo
Miquel Bioque Alcázar

Published: 20 February 2018
Updated: 30 November 2022

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.


Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.